NuVasive Financials

Based on the measurements of operating efficiency obtained from NuVasive's historical financial statements, NuVasive is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
  
Please note, the presentation of NuVasive's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NuVasive's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NuVasive's management manipulating its earnings.

NuVasive Stock Summary

NuVasive competes with Glaukos Corp, CONMED, LivaNova PLC, Masimo, and Orthopediatrics Corp. NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS6707041058
Business Address7475 Lusk Boulevard,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.nuvasive.com
Phone858 909 1800
CurrencyUSD - US Dollar

NuVasive Key Financial Ratios

NuVasive Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NuVasive's current stock value. Our valuation model uses many indicators to compare NuVasive value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuVasive competition to find correlations between indicators driving NuVasive's intrinsic value. More Info.
NuVasive is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers reporting about  0.73  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NuVasive is roughly  1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuVasive's earnings, one of the primary drivers of an investment's value.

NuVasive Thematic Clasifications

NuVasive is part of Obamacare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Companies that count on Obamacare to take off. Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program
ObamacareView
This theme covers Companies that count on Obamacare to take off. Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. Get More Thematic Ideas
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in NuVasive Stock

If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope